Abstract
With the increasing number of pharmaceutical preparations becoming available each year, it is important for both the physician who prescribes the medication, and the patient who takes it, to be aware of the intended and adverse effects associated with the use and overuse of these compounds. Contrary to most popular opinion, the medications which are most likely to cause problems are not the newer exotic drugs but the older, more widely used “safe” medications. Before a physician can hope to deal with these side effects he must be certain what medication the patient is taking and how much he has consumed. Certainly a history from the patient is of greatest importance, but often the patient is unconscious, does not remember how much he has taken, or, in the case of attempted suicide, uncooperative. In such cases the toxicology laboratory is invaluable.
Keywords
- High Pressure liqUid Chromatography
- Pharmacological Basis
- Ethacrynic Acid
- Digitalis Toxicity
- Acetaminophen Plasma Concentration
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Kaiman SM, Clark DR: Drug Assay: The Strategy of Therapeutic Drug Monitoring. New York, Masson Publishing, 1979.
Flower RJ, Moncada S, Vane JR: Analgesic-antipyretics and anti-inflammatory agents; drugs employed in the treatment of gout. In Gilman AG, Goodman LS, and Gilman A (eds): The Pharmacological Basis of Therapeutics, 6th ed. New York, Macmillan, 1980.
Kaye S: Handbook of Emergency Toxicology, 4th ed. Springfield, IL, Charles C Thomas, 1980.
Trinder P: Rapid determination of salicylate in biological fluids. Biochem J 57:301–303, 1954.
Sunshine I: Methodology for Analytical Toxicology. Cleveland, OH, CRC Press, 1975.
Grings CS, Saloom JM: Coloimetric methods for quantitation determination of acetaminophen in serum. Clin Toxicol 15:67–73, 1979.
Glynn JP, Kendal SE: Paracetamol measurement. Lancet 2:1147–1148, 1975.
Blair D, Rumack BH: Acetaminophen in serum and plasma estimated by highpressure liquid chromatography: A microscale method. Clin Chem 23:743–745, 1977.
Horvitz RA, Jatlow PI: Determination of acetaminophen concentrations in serum by high pressure liquid chromatography. Clin Chem 23:1596–1598, 1977.
Lo LY, Bye A: Rapid determination of paracetamol in plasma by reverse-phase high performance liquid chromatography. J Chromatogr 173:198–201, 1979.
Duffy JP, Byers J: Acetaminophen assay: The clinical consequences of a colorimetric vs. a high-pressure liquid chromatography determination in the assessment of two potentially poisoned patients. Clin Toxicol 15:427–435, 1979.
West JC: Rapid HPLC analysis of paracetamol (acetaminophen) in blood and postmortem viscera. J Anal Toxicol 5:118–121, 1981.
Hoffman BF, Bigger JT Jr: Digitalis and allied cardiac glycosides. In Gilman AG, Goodman LS, Gilman A (eds): The Pharmacological Basis of Therapeutics, 6th ed. New York, Macmillan, 1980.
Lindenbaum J, Butler VP, Murphy JE, et al: Correlation of digoxin-tablet dissolution rate with biological availability. Lancet 1:1215–1217, 1973.
Lindenbaum J, Mellow MH, Blackstone MO, et al: Variability in biological availability of digoxin from four preparations. N Engl J Med 285:1344–1347, 1971.
Wagner JG, Christensen M, Sakmar E, et al: Equivalence lack in digoxin plasma levels. JAMA 224:199–204, 1973.
Beller GA, Smith TW, Abelman WH, et al: Digitalis intoxication. A prospective clinical study with serum level correlations. N Engl J Med 284:989–997, 1971.
Smith TW: Digitalis toxicity: Epidemiology and clinical use of serum concentration measurements. Am J Med 58:470–476, 1975.
Watson E, Kaiman SM: Assay of digoxin in plasma by gas chromatography. J Chromatogr 56:209–218, 1971.
Okarma TB, Tramell P, Kaiman SM: The surface interaction between digoxin and cultured heart cells. J Pharmacol Exp Ther 183:559–576, 1972.
Watson E, Tramell P, Kaiman SM: Identification of submicrogram amounts of digoxin, digitoxin, and their metabolic products. J Chromatogr 69:157–163, 1972.
Watson E, Clark DR, Kaiman SM: Identification by gas chromatography-mass spectroscopy of dihydrodigoxin—a metabolite of digoxin in man. J Pharmacol Exp Ther 184:424–431, 1973.
Clark DR, Kaiman SM: Dihydrodigoxin: A common metabolite of digoxin in man. Drug Metab Dispos 2:148–150, 1974.
Lowenstein JM: A method of measuring plasma levels of digitalis glycosides. Circulation 31:228–233, 1965.
Oliver GC Jr, Parker BM, Brasfield DL, et al: The measurement of digitoxin in human serum by radioimmunoassay. J Clin Invest 47:1035–1042, 1968.
Smith TW, Butler VP Jr, Haber E: Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. N Engl J Med 281:1212–1216, 1969.
Horgan ED, Riley WJ: Radioimmunoassay of plasma digoxin, with use of iodinated tracer. Clin Chem 19:187–190, 1973.
Cerceo E, Elloso CA: Factors affecting the radioimmunoassay of digoxin. Clin Chem 18:539–543, 1972.
Ochs HR, Smith TW: Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments. J Clin Invest 60:1303–1313, 1977.
Bigger JT JR, Hoffman BF: Antiarrhythmic drugs. In Gilman AG, Goodman LS, Gilman A (eds): The Pharmacological Basis of Therapeutics, 6th ed. New York, Macmillan 1980.
Data JL, Wilkinson GR, Nies AS: Interaction of quinidine with anticonvulsant drugs. N Engl J Med 294:699–702, 1976.
Leahey EB, Reiffel JA, Drusin RE, et al: Interaction between quinidine and digoxin. JAMA 240:533–534, 1978.
Koch-Weser J: Quinidine-induced hypothrombinemic hemorrhage in patients on chronic warfarin therapy. Ann Intern Med 68:511–517, 1968.
Heissenbuttel RH, Bigger JT Jr: The effect of oral quinidine on intraventricular conduction in man. Correlation of plasma quinidine with changes in intraventricular conduction time. Am Heart J 80:453–462, 1970.
Brodie BB, Udenfriend S: The estimation of quinine in human plasma with a note on the estimation of quinidine. J Pharmacol Exp Ther 78:154, 1943.
Brodie BB, Udenfriend S, Baer JE: The estimation of basic organic compounds in biological material. J Biol Chem 168:299, 1947.
Cramer G, Isaksson B: Quantitative determination of quinidine in plasma. Scand J Clin Lab Invest 15:553–556, 1963.
Edgar AL, Sokolow M: Experiences with the photofluorometric determination of quinidine in blood. J Lab Clin Med 36:478, 1950.
Weiner N: Drugs that inhibit adrenergic nerves and block adrenergic receptors. In Gilman AG, Goodman LS, Gilman A (eds): The Pharmacological Basis of Therapeutics, 6th ed. New York, Macmillan, 1980.
Nies AS, Evans GH, Shand DG: Regional hemodynamic effects of beta-adrenergic blockade with propranolol in the unanesthetized primate. Am Heart J 85:97–102, 1973.
Ganong WF: Biogenic amines, sympathetic nerves, and renin secretion. Fed Proc 32:1782–1784, 1973.
Esler M, Zweifler A, Randall O, et al: Pathophysiologic and pharmacokinetic determinants of the antihypertensive response to propranolol. Clin Pharmacol Ther 22:299–308, 1977.
Evans GH, Nies AS, Shand DG: The disposition of propranolol. III. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog, and rat. J Pharmacol Exp Ther 186:114–122, 1973.
Nicolaescu V. Manicatide M, Stroescu V: α-Adrenergic blockade with practolol in acetylcholine-sensitive asthma patients. Respiration 29:139–154, 1972.
Greenblatt DJ, Shader RI: On the psychopharmacology of beta adrenergic blockade. Curr Ther Res 14:615–625, 1972.
Shand DB, Nuckolls EM, Oates JA: Plasma propranolol levels in adults, with observations in four children. Clin Pharmacol Ther 11:112, 1970.
Vasiliades J, Turner T, Owens C: A modified sensitive spectrofluorometric method for the determination of propranolol in serum. Am J Clin Pathol 70:793–799, 1978.
Hadzija BW, Mattocks AM: Quantitative TLC determinations of propranolol in human plasma. J Pharm Sci 67:1307–1309, 1978.
Walle T: GLC determination of propranolol, other α-blocking drugs, and metabolites in biological fluids and tissues. J Pharm Sci 63:1885–1891, 1974.
Kawashima K, Levy A, Spector S: Stereospecific radioimmunoassay for propranolol isomers. J Pharmacol Exp Ther 196:517–523, 1976.
Jatlow P, Bush W, Hochster H: Improved liquid-chromatographic determination of propranolol in plasma with fluorescence detection. Clin Chem 25: 777–779, 1979.
Nygard G, Shelver WH, Wahba Khalil SK: Sensitive high-pressure liquid Chromatographie determination of propranolol in plasma. J Pharm Sci 68:379–381, 1979.
Rosseel MT, Bogaert MG: High-performance liquid Chromatographie determination of propranolol and 4-hydroxypropranolol in plasma: J Pharm Sci 70:688–689, 1981.
Rall TW: Central nervous system stimulants. In Gilman AG, Goodman LS, Gilman A (eds): The Pharmacological Basis of Therapeutics, 6th ed. New York, Macmillan, 1980.
Kuzemko JA, Paala J: Apnoeic attacks in the newborn treated with aminophylline. Arch Dis Child 48:404–406, 1973.
Shannon DC, Gotay F, Steim IM, et al: Prevention of apnea and bradycardia in low-birthweight infants. Pediatrics 55:589–594, 1975.
Rane A, Wilson JT: Clinical pharmacokinetics in infants and children. Clin Pharmacokinet 1:2–24, 1976.
Schack JA, Waxier SH: An ultraviolet spectrophotometric method for determination of theophylline and theobromine in blood and tissues. J Pharmacol Exp Ther 97:283–291, 1949.
Jatlow P: Ultraviolet spectrophotomerry of theophylline in plasma in the presence of barbiturates. Clin Chem 21:1518–1520, 1975.
Woodman TF, Canada AT, Seidman J: Interference of allopurinol and alloxanthine in ultraviolet theophylline assay. Am J Hosp Pharm 34:984–985, 1977.
Johnson GF, Dechtiaruk WA, Solomon HM: Gas-chromatographic determination of theophylline in human serum and saliva. Clin Chem 21:144–147, 1975.
Least CJ Jr, Johnson GF, Solomon HM: Gas-chromatographic micro-scale procedure for theophylline with use of a nitrogen-sensitive detector. Clin Chem 22:765–768, 1976.
Sheehan M, Hertel RH, Kelly CT: Gas-chromatography mass-spectrometric determination of theophylline in whole blood. Clin Chem 23:64–68, 1977.
Neese AL, Soyka LF: Development of a radioimmunoassay for theophylline. Application to studies in premature infants. Clin Pharmacol Ther 21:633–641, 1977.
Gushaw JB, Hu MW, Singh P, et al: Homogeneous enzyme immunoassay for theophylline in serum. Clin Chem 23:1144, 1977.
Nelson JW, Cordry AL, Aron CG, et al: Simplified micro-scale procedure for preparing samples for theophylline determination by liquid chromatography. Clin Chem 23:124–126, 1977.
Ovcutt JJ, Kozak PP Jr, Gillman SA, et al: Micro-scale method for theophylline in body fluids by reversed-phase, high-pressure liquid chromatography. din Chem 23:599–601, 1977.
Adams RF, Vandemark FL, Schmidt GJ: More sensitive high-pressure liquid Chromatographic determination of theophylline in serum. Clin Chem 22:1903–1906, 1976.
Sande MA, Mandell GL: Antimicrobial agents: The aminoglycosides. In Gilman AG, Goodman LS, Gilman A (eds): The Pharmacological Basis of Therapeutics, 6th ed. New York, Macmillan, 1980.
Barza M, Brown RB, Shen D, et al: Predictability of blood levels of gentamicin in man. J Infect Dis 132:165–174, 1975.
Barza M, Scheife RT: Antimicrobial spectrum, pharmacology, and therapeutic use of antibiotics. J Maine Med Assoc 68:194–210, 1977.
Mathog RH, Capps MJ: Ototoxic interactions of ethacrynic acid and streptomycin. Ann Otol Rhinol Laryngol 86:158–163, 1977.
Gary NE, Buzzeo L, Solaki J, et al: Gentamicin-associated acute renal failure. Arch Intern Med 126:1101–1104, 1976.
Sabath LD, Casey JI, Rich PA, et al: Rapid microassay for circulating nephrotoxic antibiotics. Antimicrob Agents Chemother 83-90, 1970.
Lewis JE, Nelson JC, Elder HA: Radioimmunoassay of an antibiotic, gentamicin: Nature New Biol 239:214–216, 1972.
Smith DA, Van Otto B, Smith AL: Rapid chemical assay for gentamicin. New Engl J Med 286:583–596, 1972.
Alcid DV, Seligman SJ: Simplified assay for gentamicin in the presence of other antibiotics. Antimicrob Agents Chemother 3:559–561, 1973.
Peng GW, Gadalla MAF, Peng A et al: High-pressure liquid-Chromatographic method for determination of gentamicin in plasma. Clin Chem 23:1838–1844, 1977.
Douglas WW: Histamine and 5-hydroxytryptamine (serotonin) and their antagonists. In Gilman AG, Goodman LS, and Gilman A (eds): The Pharmacological Basis of Therapeutics, 6th ed. New York, Macmillan, 1980.
Carruthers SG, Shoeman DW, Hignite CE, et al: Correlation between plasma diphenhydramine level and sedative and antihistamine effects. Clin Phrmacol Ther 23:375–382, 1978.
Glazko AJ, Dill WA, Fransway RL: Determination of diphenhydramine blood levels using a new fluorescent dye-salt procedure generally applicable to basic organic compounds. Fed Proc 21:269, 1962.
Albert KS, Sakmar E, Movais JA, et al: Determination of diphenhydramine in plasma by gas chromatography. Res Commun Chem Pathol Pharmacol 7: 95–103, 1974.
Bilzer W, Gundert-Remy V: Determination of nanogram quantities of diphenhydramine and orphenadrine in human plasma using gas-liquid chromatography. Eur J Clin Pharmacol 6:268–270, 1973.
Rights and permissions
Copyright information
© 1984 Spectrum Publications, Inc.
About this chapter
Cite this chapter
Freeman, A.M., Shory, C.B. (1984). Blood Level Determinations of Commonly Prescribed Medical Drugs. In: Handbook of Psychiatric Diagnostic Procedures Vol. I. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-6725-3_7
Download citation
DOI: https://doi.org/10.1007/978-94-011-6725-3_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-6727-7
Online ISBN: 978-94-011-6725-3
eBook Packages: Springer Book Archive